nach oben

Virchows Archiv

Erschienen in:

28.04.2016 | Letter to the Editor

HOXB13 expression in metastatic prostate cancer

verfasst von: Valeria Barresi, Antonio Ieni, Luca Reggiani Bonetti, Giovanni Tuccari

Erschienen in: Virchows Archiv | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Excerpt

To the Editor. …

Varinot J, Furudoï A, Drouin S, Phe V, Penna RR, Roupret M, Bitker MO, Cussenot O, Compérat E (2016) HOXB13 protein expression in metastatic lesions is a promising marker for prostate origin. Virchows Arch. doi:10.1007/s00428-016-1917-x

Varinot J, Cussenot O, RoupretM CP, Bitker M-O, ChartierKastler E, et al. (2013) HOXB13 is a sensitive and specific marker of prostate cells, useful in distinguishing between carcinomas of prostatic and urothelial origin. Virchows Arch 463:803–809CrossRefPubMed

Barresi V, Ieni A, Cardia R, Licata L, Vitarelli E, Reggiani Bonetti L, Tuccari G (2016) HOXB13 as an immunohistochemical marker of prostatic origin in metastatic tumors. APMIS 124:188–193CrossRefPubMed

Alshenawy HA, Saied E (2015) Do HOXB13 and P63 have a role in differentiating poorly differentiated prostatic carcinoma from urothelial high-grade carcinoma? APMIS 123:772–778CrossRefPubMed

Titel: HOXB13 expression in metastatic prostate cancer
verfasst von: Valeria Barresi
Antonio Ieni
Luca Reggiani Bonetti
Giovanni Tuccari
Publikationsdatum: 28.04.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: Virchows Archiv / Ausgabe 1/2016
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI: https://doi.org/10.1007/s00428-016-1946-5

Neu im Fachgebiet Pathologie

Open Access 15.04.2024 | Biomarker | Schwerpunkt: Next Generation Pathology

Springer Medizin

HOXB13 expression in metastatic prostate cancer

Excerpt

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Personalisierte Medizin in der Onkologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2016

In a cohort of breast cancer screened patients the proportion of HER2 positive cases is lower than that earlier reported and pathological characteristics differ between HER2 3+ and HER2 2+/Her2 amplified cases

Immunohistochemical demonstration of EphA2 processing by MT1-MMP in invasive cutaneous squamous cell carcinoma

Unclassified renal cell carcinoma with tubulopapillary architecture, clear cell phenotype, and chromosome 8 monosomy: a new kid on the block

Postmortem CT is more accurate than clinical diagnosis for identifying the immediate cause of death in hospitalized patients: a prospective autopsy-based study

Telomere length shortening in gastric mucosa is a field effect associated with increased risk of gastric cancer